LRRK2 and Parkinson disease: In contrast, splenocytes obtained from mice carrying the PD-associated VPS35-D620N mutation known to enhance LRRK2 activity (Mir et al, 2018) displayed strongly elevated LRRK2 activity in all cell types apart from T cells (Fig. 1F).